title: Protein binding of antiepileptic drugs during pregnancy, labor, and puerperium.
abstract: Twenty-four epileptic women were followed-up during late pregnancy, labor, and early puerperium in order to detect possible alterations in serum protein binding of antiepileptic drugs (AEDs). The total and free concentrations of carbamazepine (CBZ), phenytoin (PHT), and valproate (VPA) in maternal serum were measured. In addition, the concentrations of albumin, alpha 1-acid glycoprotein (AGP), and free fatty acids (FFA) were also measured. Total AED concentrations during labor were influenced by changes in drug dosages; total PHT increased during the first puerperal weeks. During labor the free fraction of CBZ remained stable, whereas PHT and particularly VPA free fractions increased. This phenomenon was parallel to the increase in FFA concentration; FFA concentrations decreased again during the first days postpartum. Albumin and AGP concentrations were low during pregnancy and labor, and increased after delivery. The total umbilical CBZ and PHT concentrations were not significantly different from maternal concentrations. The total VPA concentration in umbilical serum was significantly higher than that in maternal serum. The free fraction of CBZ was higher and that of PHT and VPA lower in umbilical than in maternal serum at delivery. Umbilical cord serum had a higher albumin but a lower AGP and FFA concentration than maternal serum. The changes in PHT and particularly VPA free fraction associated with changes in FFA concentration should be considered when assessing the total concentration of these drugs in maternal and umbilical serum.
authors.affiliation: Department of Clinical Pharmacology, University of Helsinki, Finland.
authors.forename: A H
authors.initials: AH
authors.lastname: Bardy
authors.forename: V K
authors.initials: VK
authors.lastname: Hiilesmaa
authors.forename: K
authors.initials: K
authors.lastname: Teramo
authors.forename: P J
authors.initials: PJ
authors.lastname: Neuvonen
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000097:blood / Q000493:pharmacokinetics*; D002220:Carbamazepine / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D006801:Humans; D007743:Labor, Obstetric / Q000378:metabolism*; D009961:Orosomucoid / Q000378:metabolism; D010672:Phenytoin / Q000097:blood; D049590:Postpartum Period / Q000378:metabolism*; D011247:Pregnancy / Q000378:metabolism*; D011485:Protein Binding; D012640:Seizures / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D000927:Anticonvulsants; D005230:Fatty Acids, Nonesterified; D009961:Orosomucoid; D012709:Serum Albumin; D002220:Carbamazepine; D010672:Phenytoin